These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 8548778)
21. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Miller DP; Liu G; De Vivo I; Lynch TJ; Wain JC; Su L; Christiani DC Cancer Res; 2002 May; 62(10):2819-23. PubMed ID: 12019159 [TBL] [Abstract][Full Text] [Related]
22. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand. Pisani P; Srivatanakul P; Randerson-Moor J; Vipasrinimit S; Lalitwongsa S; Unpunyo P; Bashir S; Bishop DT Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):667-74. PubMed ID: 16614107 [TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk. Gsur A; Haidinger G; Hollaus P; Herbacek I; Madersbacher S; Trieb K; Pridun N; Mohn-Staudner A; Vetter N; Vutuc C; Micksche M Anticancer Res; 2001; 21(3C):2237-42. PubMed ID: 11501853 [TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression. Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060 [TBL] [Abstract][Full Text] [Related]
25. Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants. Bufalo NE; Leite JL; Guilhen AC; Morari EC; Granja F; Assumpcao LV; Ward LS Endocr Relat Cancer; 2006 Dec; 13(4):1185-93. PubMed ID: 17158763 [TBL] [Abstract][Full Text] [Related]
26. Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study. Quiñones LA; Irarrázabal CE; Rojas CR; Orellana CE; Acevedo C; Huidobro C; Varela NE; Cáceres DD Asian J Androl; 2006 May; 8(3):349-55. PubMed ID: 16625286 [TBL] [Abstract][Full Text] [Related]
27. Screening of homologous recombination gene polymorphisms in lung cancer patients reveals an association of the NBS1-185Gln variant and p53 gene mutations. Medina PP; Ahrendt SA; Pollan M; Fernandez P; Sidransky D; Sanchez-Cespedes M Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):699-704. PubMed ID: 12917199 [TBL] [Abstract][Full Text] [Related]
28. [Role of metabolic polymorphisms in lung carcinogenesis]. Kiyohara C; Ohno Y Nihon Koshu Eisei Zasshi; 1999 Apr; 46(4):241-9. PubMed ID: 10491856 [TBL] [Abstract][Full Text] [Related]
29. p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer. Husgafvel-Pursiainen K; Boffetta P; Kannio A; Nyberg F; Pershagen G; Mukeria A; Constantinescu V; Fortes C; Benhamou S Cancer Res; 2000 Jun; 60(11):2906-11. PubMed ID: 10850436 [TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers. Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921 [TBL] [Abstract][Full Text] [Related]
31. Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer. Tan C; Xu HY; Zhang CY; Zhang H; Chen CM; Zhang WM; Sun XY; Jin YT Arch Med Res; 2011 Nov; 42(8):669-76. PubMed ID: 22154617 [TBL] [Abstract][Full Text] [Related]
32. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer. Hu Y; McDermott MP; Ahrendt SA Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626 [TBL] [Abstract][Full Text] [Related]
33. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study. Wenzlaff AS; Cote ML; Bock CH; Land SJ; Schwartz AG Carcinogenesis; 2005 Feb; 26(2):395-401. PubMed ID: 15528218 [TBL] [Abstract][Full Text] [Related]
34. GSTM1, P53 and K-ras molecular detection in resectable non-small cell lung cancer by denaturing gradient gel electrophoresis-bronchoalveolar lavage fluid analysis. Curigliano G; Ferretti G; Mandalà M; De Pas T; Calabrò MG; Solli P; Noberasc C; de Braud F Anticancer Res; 2001; 21(5):3461-9. PubMed ID: 11848510 [TBL] [Abstract][Full Text] [Related]
35. The p53 codon 72 polymorphism and lung cancer risk. Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785 [TBL] [Abstract][Full Text] [Related]
36. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes. Rojas M; Alexandrov K; Cascorbi I; Brockmöller J; Likhachev A; Pozharisski K; Bouvier G; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H Pharmacogenetics; 1998 Apr; 8(2):109-18. PubMed ID: 10022748 [TBL] [Abstract][Full Text] [Related]
37. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Liu G; Miller DP; Zhou W; Thurston SW; Fan R; Xu LL; Lynch TJ; Wain JC; Su L; Christiani DC Cancer Res; 2001 Dec; 61(24):8718-22. PubMed ID: 11751390 [TBL] [Abstract][Full Text] [Related]
38. Individual differences in lung cancer susceptibility in relation to polymorphisms of P-450IA1 gene and cigarette dose. Kawajiri K; Nakachi K; Imai K; Hayashi S; Watanabe J Princess Takamatsu Symp; 1990; 21():55-61. PubMed ID: 2134690 [TBL] [Abstract][Full Text] [Related]
39. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Nakachi K; Imai K; Hayashi S; Watanabe J; Kawajiri K Cancer Res; 1991 Oct; 51(19):5177-80. PubMed ID: 1655248 [TBL] [Abstract][Full Text] [Related]
40. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Ko Y; Abel J; Harth V; Bröde P; Antony C; Donat S; Fischer HP; Ortiz-Pallardo ME; Thier R; Sachinidis A; Vetter H; Bolt HM; Herberhold C; Brüning T Cancer Res; 2001 Jun; 61(11):4398-404. PubMed ID: 11389067 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]